Cost-effectiveness of a Ceramide-Infused Skin Barrier Versus a Standard Barrier: Findings From a Long-Term Cost-effectiveness Analysis: Erratum.

In the second paragraph of the article, under the Introduction, the last sentence indicates that “55.4% of subjects allocated to the CIB experienced PSCs versus 40.5% of control subjects (P = .069”. The corrected sentence is listed below.

“In addition, 40.5% of subjects allocated to CIB experienced PSCs versus 55.4% of control subjects; p=0.069.”